Entities Covered by the Regulation
- The regulation applies to both public and private institutions involved in drug-related activities, including:
- Hospitals
- Drug/chemical manufacturers, importers, exporters, and distributors
- Forensic and drug testing laboratories
- Drug treatment and rehabilitation facilities
- Accredited physicians
- Drug law enforcement, prosecution agencies
- Penal facilities
- These entities must submit reports on drug-related treatment, transactions, handling, arrests, cases, and prison drug profiles.
Key Definitions
- Controlled Precursors and Essential Chemicals: Substances listed under UN Conventions and classified by DDB.
- Dangerous Drugs: Substances listed under various international drug conventions and classified by DDB.
- DDB IDADIN: The integrated data network established by this regulation.
- DOH-Accredited Physician: Authorized physicians conducting drug dependency examinations outside facilities.
- Drug Analysis: Identification and characterization of seized drugs and chemicals.
- Drug/Chemical Distributor, Exporter, Importer, Manufacturer: Persons authorized to handle dangerous drugs and controlled substances as defined.
- Drug-Related Arrest: Apprehension for violations of drug laws or crimes under influence of drugs.
- Drug Testing Laboratory: Facility capable of testing specimens for dangerous drugs.
- Drug Treatment and Rehabilitation: Processes for administering care and support to drug dependents.
- Forensic Laboratory: Laboratories maintained by Philippine law enforcement agencies.
- Penal Facilities: Managed by national and local correctional agencies.
- Prosecution Agencies: Offices for prosecuting drug-related cases.
- Public and Private Drug Treatment/Rehabilitation Facilities: Institutions providing care and social re-integration services.
- Public and Private Hospitals: Facilities treating drug-related cases.
Reporting Mechanisms and Specific Report Forms
- Standardized reporting forms are prescribed for consistency and clarity.
- Mandatory forms cover various aspects, including:
- Drug-related treatments and admissions (Form 1-06)
- Approved transactions of dangerous drugs and chemicals (Forms 2-06 to 5-06)
- Drug treatment and rehabilitation data (Form 6-06)
- Drug analysis and laboratory reports (Forms 7-06, 8-06)
- Drug law enforcement activities: arrests, searches, seizures, prosecutions (Forms 9-06 to 13-06)
- Reporting frequency ranges from quarterly to semi-annually depending on the form and data type.
Submission Procedures
- All requisite reports must be submitted to the Executive Director of the Dangerous Drugs Board.
- Reports are due within fifteen (15) days following the end of the reporting period.
Sanctions for Non-Compliance
- Failure or refusal to submit the required reports is punishable under Section 32 of R.A. 9165.
- Criminal liability may be imposed as prescribed by law.
Effectivity and Implementation
- The regulation takes effect fifteen (15) days after publication in two newspapers of general circulation.
- Registration with the Office of the National Administrative Register is also required for validity.
- Adopted and enforced by the DDB Chairman and Secretary with relevant attestations.